This content is machine translated The ageing lung Cellular ageing and senescence What are the causes that lead to an inadequate response to insults? How does an organ like the lung change with age, making the older population more susceptible to age-related… CME-Test
View Post 3 min This content is machine translated New S3 Guideline Lung Cancer Improve prevention, diagnostics, therapy and aftercare Today, the treatment of lung cancer is much more differentiated and also more complicated than it was ten years ago. This is due not least to the great dynamism in…
View Post 5 min This content is machine translated Lung cancer Lung cancer in focus: What’s new? Overall survival of patients with lung cancer has increased by approximately 15% over the past decade. This is primarily due to new therapeutic options, including targeted drugs. However, in order…
View Post 16 min This content is machine translated Bronchial carcinoma New approaches in therapy Bronchial carcinomas are the leading cause of cancer-related deaths worldwide. With the development of immune checkpoint inhibitors, the therapeutic landscape has changed significantly.
View Post 4 min This content is machine translated PD1/PD-L1 in second-line therapy for metastatic NSCLC. The agony of choice The treatment of bronchial carcinoma is greatly changed by immunotherapy. Current developments will lead to an adjustment of our therapy algorithms in the coming months.
View Post 2 min This content is machine translated Non-small cell lung cancer CheckMate 057 with promising results Patients with advanced non-squamous type non-small cell lung cancer (NSCLC) benefit from nivolumab after failed platinum-containing chemotherapy. This is the conclusion of the CheckMate 057 study. The tested substance was…
View Post 2 min This content is machine translated Lung cancer Living longer thanks to cancer? A current forecast [1] for the year 2015, which is based on statistics from the WHO and data from individual European countries, indicates that theThe picture regarding lung cancer is…
View Post 4 min This content is machine translated Onco-training in St. Gallen Targeted systems therapy in metastatic NSCLC. In more than half of all patients with lung cancer, metastases are already present at the time of diagnosis. In recent years, new compounds have been developed that can be…
